Mexico - Delayed Quote MXN

Hologic, Inc. (HOLX.MX)

1,207.71

0.00

(0.00%)

At close: April 15 at 5:30:23 AM CST

What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?

Let's talk about the popular Hologic, Inc. ( NASDAQ:HOLX ). The company's shares saw significant share price movement...

Simply Wall St. 4 days ago

HOLX
Wayde McMillan Elected to Hologic Board of Directors

MARLBOROUGH, Mass., April 04, 2025--Wayde McMillan Elected to Hologic Board of Directors

Business Wire 14 days ago

HOLX
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

MARLBOROUGH, Mass., April 03, 2025--Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

Business Wire 15 days ago

HOLX
Investing in Hologic (NASDAQ:HOLX) five years ago would have delivered you a 76% gain

It hasn't been the best quarter for Hologic, Inc. ( NASDAQ:HOLX ) shareholders, since the share price has fallen 15% in...

Simply Wall St. 25 days ago

HOLX
Hologic cut to Hold at Argus amid slower mammography equipment sales

Argus downgraded Hologic (HOLX) to Hold from Buy. The firm is citing a higher risk to the management’s FY25 outlook as the company has reduced its revenue guidance due to slower sales of mammography capital equipment, the analyst tells investors in a research note. Argus further notes risks from disruption to AIDS-prevention work as USAID funding is halted and from tariffs given that Hologic uses contract manufacturers in Mexico. Published first on TheFly – the ultimate source for real-time, mar

TipRanks last month

HOLX
Here's What To Make Of Hologic's (NASDAQ:HOLX) Decelerating Rates Of Return

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Simply Wall St. last month

HOLX
Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software

MARLBOROUGH, Mass., February 20, 2025--Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software

Business Wire last month

HOLX
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay

MARLBOROUGH, Mass., February 18, 2025--Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay

Business Wire last month

HOLX
Hologic, Inc. (NASDAQ:HOLX) Just Reported Earnings, And Analysts Cut Their Target Price

It's been a mediocre week for Hologic, Inc. ( NASDAQ:HOLX ) shareholders, with the stock dropping 10% to US$64.58 in...

Simply Wall St. 2 months ago

HOLX
Reddit initiated, Cigna downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top Upgrades: Evercore ISI upgraded CarMax (KMX) to Outperform from In Line with a price target of $110, up from $90. The firm sees the company’s improving comp and share trends persisting amid a favorable industry backdrop. Exane BNP Paribas upgraded Array Technologies (ARRY) to Neutral from Underperform with a $9 pr

TipRanks 2 months ago

MTCH

CI

TTEK
Hologic First Quarter 2025 Earnings: EPS Beats Expectations

Hologic ( NASDAQ:HOLX ) First Quarter 2025 Results Key Financial Results Revenue: US$1.02b (flat on 1Q 2024). Net...

Simply Wall St. 2 months ago

HOLX
Hologic Announces Financial Results for First Quarter of Fiscal 2025

MARLBOROUGH, Mass., February 05, 2025--Hologic Announces Financial Results for First Quarter of Fiscal 2025

Business Wire 2 months ago

HOLX
New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide

DAVOS, Switzerland, January 21, 2025--New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide

Business Wire 2 months ago

HOLX
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025

MARLBOROUGH, Mass., January 12, 2025--Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025

Business Wire 3 months ago

HOLX
Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025

MARLBOROUGH, Mass., January 06, 2025--Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025

Business Wire 3 months ago

HOLX
Hologic Completes Acquisition of Gynesonics, Inc.

MARLBOROUGH, Mass., January 06, 2025--Hologic Completes Acquisition of Gynesonics, Inc.

Business Wire 3 months ago

HOLX
Hologic price target lowered to $76 from $81 at Evercore ISI

Evercore ISI lowered the firm’s price target on Hologic (HOLX) to $76 from $81 and keeps an In Line rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science Tools and Diagnostics, the analyst argues that FY25 guides from the life science tools group are likely to be conservative on China and Pharma, while in MedTech the firm contends that “healthy” utilization trends and a margin expansion thesis support the group. Published first on TheFly – the ultimate source for real-t

TipRanks 3 months ago

HOLX
Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC

MARLBOROUGH, Mass., December 18, 2024--Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC

Business Wire 3 months ago

HOLX
Hologic initiated with a Peer Perform at Wolfe amid near-term headwinds

As previously reported, Wolfe Research analyst Doug Schenkel initiated coverage of Hologic (HOLX) with a Peer Perform rating and no price target The Diagnostics & Med Tech company caters to the healthcare and clinical end markets and the firm calls the company “an intriguing asset with a strong management team and unique portfolio.” However, while material downside risk is likely limited from here, the firm feels near term respiratory headwinds and saline shortages likely make expectations too h

TipRanks 4 months ago

HOLX
Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines

MARLBOROUGH, Mass., December 10, 2024--Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines

Business Wire 4 months ago

HOLX

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Hologic, Inc. (HOLX.MX)

What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?

Wayde McMillan Elected to Hologic Board of Directors

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

Investing in Hologic (NASDAQ:HOLX) five years ago would have delivered you a 76% gain

Hologic cut to Hold at Argus amid slower mammography equipment sales

Here's What To Make Of Hologic's (NASDAQ:HOLX) Decelerating Rates Of Return

Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software

Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay

Hologic, Inc. (NASDAQ:HOLX) Just Reported Earnings, And Analysts Cut Their Target Price

Reddit initiated, Cigna downgraded: Wall Street’s top analyst calls

Hologic First Quarter 2025 Earnings: EPS Beats Expectations

Hologic Announces Financial Results for First Quarter of Fiscal 2025

New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide

Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025

Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025

Hologic Completes Acquisition of Gynesonics, Inc.

Hologic price target lowered to $76 from $81 at Evercore ISI

Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC

Hologic initiated with a Peer Perform at Wolfe amid near-term headwinds

Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines